LexaGene Holdings Inc. (CVE:LXG – Get Free Report)’s stock price fell 19.2% during mid-day trading on Monday . The company traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares traded hands during mid-day trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Trading Down 19.2 %
The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 138.01. The firm has a market cap of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26. The company’s fifty day moving average price is C$0.11 and its two-hundred day moving average price is C$0.11.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Stories
- Five stocks we like better than LexaGene
- Investing in Construction Stocks
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- The 3 Best Fintech Stocks to Buy Now
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- The Basics of Support and Resistance
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
